Cargando…
13.4 CANNABINOID RECEPTOR GENE POLYMORPHISMS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA
BACKGROUND: Cognition is a major determinant of functioning in patients with schizophrenia. There is evidence that the endocannabinoid system influences cognition in human subjects, and participates in the pathophysiology of schizophrenia. In a previous study, we have shown that the expression of ca...
Autores principales: | Salgado, Joao, Ferretjans, Rodrigo, Panizzutti, Bruna, Rosa, Eduarda, Gama, Clarissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887465/ http://dx.doi.org/10.1093/schbul/sby014.052 |
Ejemplares similares
-
Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls
por: Ferretjans, Rodrigo, et al.
Publicado: (2021) -
13.3 EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018) -
T68. DIFFERENT INFLUENCES OF INTELLECTUAL FUNCTIONING AND COGNITIVE PERFORMANCE TO FUNCTIONAL OUTCOMES IN SCHIZOPHRENIA AND HEALTHY CONTROLS
por: Czepielewski, Leticia, et al.
Publicado: (2018) -
T81. LONG-TERM COURSE OF COGNITIVE PERFORMANCE IN PATIENTS WITH CHRONIC SCHIZOPHRENIA
por: Martins, Thaís, et al.
Publicado: (2018) -
T134. EXPOSURE TO NITROGEN DIOXIDE DURING CHILDHOOD IS ASSOCIATED WITH INCREASED RISK OF SCHIZOPHRENIA
por: Antonsen, Sussie, et al.
Publicado: (2018)